NR2E3 and lung cancer: Treatment with TSA and NAM significantly reduced RNR activity in normal lung epithelial (i.e., BEAS-2B and HBEC3) and human lung cancer cell lines (i.e., H1299 and H460) (Fig. 1a, b).